Search Within

Isabelle C Riviere

  1. "Jae Park"
  2. "Adult Leukemia"
  3. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (55)
  2. Journal Article (17)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (73)
  2. Center for Hematologic Malignancies (73)
  3. Department of Medicine (73)
  4. GSK Faculty (73)
  5. Hematologic Malignancies Research (73)
  6. Hematologic Malignancies, Division of (73)

More Groups

People
  1. Jae Park (73)
  2. Michel Sadelain (73)
  3. Renier Brentjens (65)
  4. Xiuyan Wang (56)
  5. Brigitte Senechal (30)
  6. Kevin Curran (28)

More People

Years
  1. 2023 (6)
  2. 2022 (6)
  3. 2021 (6)
  4. 2020 (1)
  5. 2019 (6)
  6. 2018 (6)

More Years

Publications
  1. Blood (25)
  2. Journal of Clinical Oncology (11)
  3. Molecular Therapy (6)
  4. Haematologica (5)
  5. Cancer Research (3)
  6. Hematological Oncology (3)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. American Society of Clinical Oncology (12)
  3. Nature Publishing Group (11)
  4. Ferrata Storti Foundation (5)
  5. American Association for Cancer Research (4)
  6. Wiley Blackwell (3)

More Publishers

Results (73)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated results: Phase I trial of autologous CD19-targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Meeting Abstract

    Geyer, M. B.; Park, J. H.; Riviere, I.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Implications of concurrent ibrutinib therapy on CAR T-cell manufacturing and phenotype and on clinical outcomes following CD19-targeted CAR T-cell administration in adults with relapsed/refractory CLL
    Meeting Abstract

    Geyer, M. B.; Park, J. H.; Riviere, I.; Senechal, B.; Wang, X.; Purdon, T. J.; Sadelain, M. W.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy
    Meeting Abstract

    Geyer, M.; Park, J.; Rivière, I.; Senechal, B.; Hsu, M.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Impact of disease burden on long-term outcome of CD19-targeted CAR modified T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Sadelain, M.; Brentjens, R.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cells for cancer immunotherapy
    Meeting Abstract

    Curran, K. J.; Silverman, L. B.; Kobos, R.; Kernan, N. A.; Margossian, S. P.; Park, J. H.; Sauter, C. S.; Szenes, V.; Wang, X. Y.; O'Reilly, R. J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • CD19 CAR therapy for acute lymphoblastic leukemia
    Journal Article

    Sadelain, M.; Brentjens, R.; Rivière, I.; Park, J.
    American Society of Clinical Oncology Educational Book (2015)

    Fulltext@MSK | Save
  • Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Halton, E.; Quintanilla, H.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save